Eli Lilly and Company is dedicated to developing innovative new cancer medicines that will make a meaningful difference to people living with cancer.
At Lilly, we are dedicated to developing and delivering innovative medicines that will make a meaningful difference to cancer patients. For us, this means putting an intense focus on the latest scientific advances and collaborating with doctors, other researchers, advocates and payers to ensure our medicines bring value to people living with cancer.
People living with cancer are at the centre of what we do. We believe health care makes a difference only when it improves peoples' lives. Whether it's treating rare tumour types, leveraging precision medicine, continuing the study of immuno-oncology or discovering new ways to advance existing treatments, we're dedicated to making even greater differences in the lives of people living with cancer.
Improving Screening for Breast and Cervical Cancer in Kenya
As part of our Global Health programme, Lilly provides community health screenings through AMPATH, Lilly’s global health partner in Kenya. Through product and financial donations, Lilly and the Lilly Foundation support the AMPATH consortium, including AMPATH’s oncology centre and mobile screening programme for breast and cervical cancer.
Pastor, former nurse, mother and cancer warrior who supports others on their journey – Nancy Odari is all of these and more. “I want to encourage people to know that having cancer is not the end of life. It’s a new start of life”. Today, Nancy helps others get screening for early detection. “In every life, you know there’s a purpose for it.”
Learn more about Nancy and others' stories in the Corporate Responsibility and Sustainability Report.